Saturday, September 26, 2026

Corporatist Medicare for All?

Polls show that many Democrats and over a third of Americans support “Medicare for All,” a proposal to have the federal government cover all healthcare expenses while allowing privately-owned hospitals, drug companies, and medical practices to continue operating. By being the sole payer, the government could impose its plan on these businesses, potentially leading to a fully socialized healthcare system.

Despite generally negative views of federal agencies, the popularity of this type of healthcare reform raises questions. Many Americans may not grasp the economic arguments against socialism or examples of socialized healthcare problems, yet they recognize that federal bureaucracies are not effective or affordable. Their key concern, as noted in a Kaiser Family Foundation poll, is the high out-of-pocket costs of private health plans. A significant portion of the population fears they cannot afford necessary healthcare, indicating a potential appeal to proposals like “Medicare for All.” However, framing this reform as just an extension of Medicare benefits misleads many about its potential impact.

Currently, the federal government covers only about 31% of total healthcare costs, while state and local governments contribute 16%. Transitioning to a fully socialized healthcare system would likely worsen current issues. This does not minimize the public's real concerns about healthcare affordability, which stem from market-distorting government privileges, subsidies, and regulations that inflate healthcare costs. Since the late 1800s, lobbying by organizations such as the American Medical Association has limited the number of doctors and controlled drug prices, resulting in Americans paying significantly more for healthcare compared to other developed countries.

The insurance sector, often criticized, actually has low profit margins and mainly transfers costs from healthcare providers to consumers. To effectively reduce healthcare costs, attention should shift to Big Pharma and its monopoly through patents and regulations, which inflate prices. Abolishing these privileges and introducing competition could lower costs. Additionally, removing licensing barriers to medical professions could enhance access to healthcare. Private insurance companies could work to ensure standards without government-imposed restrictions.

Opponents of private healthcare may argue that a single-payer system could implement cost controls, but there are no guarantees that this would happen in practice. Concentrating purchasing power in the hands of the government might not prevent privileged interests from continuing to benefit at consumer expense. The government, through programs like Medicare and Medicaid, has contributed to inflated healthcare demand and costs. Unconditional benefits lead to higher spending and unhealthy lifestyles without consideration for costs.

Furthermore, true improvements in living standards depend on personal savings and responsibility, which government programs like Medicare have diminished over time. Since the introduction of Medicare in the 1960s, America’s savings have plummeted, indicating an urgent need for economic reforms. Instead of pursuing a “Medicare for All” approach, a shift towards reducing government involvement in healthcare—illustrated by the idea of “Medicare for None”—is necessary for future economic health and growth. 

https://mises.org/mises-wire/corporatist-medicare-all

No comments:

Post a Comment

Update on Today’s Supreme Court Order

 The Supreme Court delivered a significant ruling regarding the Department of Homeland Security's SAVE system, allowing states to verify...